Depakote Sprinkle

Trials

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

300 participants · First posted Aug 20, 2003

Completed

NCT00646711

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

16 participants · First posted Mar 28, 2008

Completed

NCT00102713

A Study for Treatment of Partial Seizures in Children

50 participants · First posted Feb 2, 2005

Drugs

View all 10 →

Small Molecule

Approved

Valproic acid(Depakene, Depakote, Epival)

Manufacturer: Banner pharmacaps inc, Abbott laboratories pharmaceutical products div +12 more

Conditions: Bipolar Disorder (BD), Complex Partial Seizure Disorder +5 more

C₈H₁₆O₂

Small Molecule

Approved

Valbenazine(Ingrezza)

Conditions: Chorea, Tardive Dyskinesia (TD)

C₂₄H₃₈N₂O₄ · Rx

Small Molecule

Approved

Topiramate(Eprontia, Qsymia, Qudexy, Topamax, Trokendi)

Manufacturer: Ortho mcneil janssen pharmaceuticals inc, Barr laboratories inc +18 more

Conditions: Alcohol Dependency, Epilepsy, Primary Generalized Tonic-Clonic Seizures +7 more

C₁₂H₂₁NO₈S · Rx

News

View all 23 →

last year

Epilepsy Drug Pipeline Shows Robust Growth with 90+ Therapies in Development Across 75+ Companies

last year

FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation

2 years ago

Trials

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

A Study for Treatment of Partial Seizures in Children

Drugs

Valproic acid(Depakene, Depakote, Epival)

Valbenazine(Ingrezza)

Topiramate(Eprontia, Qsymia, Qudexy, Topamax, Trokendi)

News

Epilepsy Drug Pipeline Shows Robust Growth with 90+ Therapies in Development Across 75+ Companies

FDA Approves Doptelet for Pediatric Immune Thrombocytopenia with New Sprinkle Formulation

Eton Pharmaceuticals Submits NDA to FDA for ET-400 (Hydrocortisone Oral Solution)